AnalytiCon Discovery GmbH

General information

AnalytiCon Discovery GmbH
Hermannswerder Haus 17
14473 Potsdam, Brandenburg
Germany

Contact person: Lutz Müller-Kuhrt, Chief Executive Officer
Company main phone: +49 (331) 2300300
Company main fax: +49 (331) 2300333
Website: https://www.ac-discovery.com

Year founded:	2000
Source of foundation:	Independent foundation

Corporate description / mission:
AnalytiCon Discovery GmbH operates as a drug discovery company. The company offers a natural product (NP) chemistry platform for NP procurement, NP derivatives, NP focused libraries, total synthesis, medicinal chemistry, and scale up of NCEs, and a biology platform for compound screening and profiling, assay development/biochemistry, lead generation biology, and discovery biology.

State of ownership: Subsidiary
Headquarters: HQ: No

Remarks on ownership / listings
AnalytiCon Discovery has been part of the BRAIN Group since 2013.

Categorization

Sector:

Biotechnology - R&D Services

Subsector:

Analytical services
Screening
Synthesis services

Primary therapeutic areas:

Musculoskeletal system and connective tissue / Orthopedics
Neoplasms / cancer / oncology
Respiratory / pulmonology
Skin and subcutaneous tissue / dermatology

Business model:

R&D
Service company
Subsidiary
Supplier / Distributor

Customer segments:

Large biotech & big pharma
Small biotech

Summary Products / Services / Technologies

Description of products:
MEGx Natural Products compound library
NATx Semi-synthetic compound libraries
MACROx NP derived macrocyclic compound libraries
Synthesis of small molecules libraries
Covering all aspects of pure compound isolation
Natural Product screening
Total synthesis of NP
Early SAR (hit expansion)
Identification of alternative sources
Tagging or labelling of NP

Collaborations & Clients

Partnering strategy / collaborations:
Merck KGaA
BRAIN AG